{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:02:37Z","timestamp":1793862157399,"version":"4.6.1"},"reference-count":32,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Angiotensin receptor neprilysin inhibitor (ARNI) and sodium-glucose co-transporter 2 inhibitors (SGLT2i) are essential medications in heart failure (HF) therapy, and their potential antiarrhythmic effects have been reported. Recently, ARNI and SGLT2i use for HF in adult congenital heart disease (ACHD) has been studied. However, whether any beneficial effects may be achieved on the arrhythmic burden in the complex population of ACHD with a systemic right ventricle (sRV) is still to be determined. Methods: We retrospectively collected all significant arrhythmic events from a cohort of patients with a failing sRV attending our tertiary care center on optimal guideline-directed medical therapy (GDMT) with ARNI and\/or SGLT2i. Results: A total of 46 patients (mean age 38.2 \u00b1 10.7 years, 58% male) on sacubitril\/valsartan were included. Twenty-three (50%) patients were also started on dapagliflozin. After a median follow-up of 36 [Q1\u2013Q3: 34\u201338] months, arrhythmic events occurred globally in 13 (28%) patients. Survival analysis showed significant reduction of clinically relevant atrial and ventricular arrhythmia at follow-up (p = 0.027). Conclusions: Our findings suggest that GDMT including sacubitril\/valsartan and dapagliflozin may also offer an antiarrhythmic effect in ACHD patients with a failing sRV, by reducing the incidence of arrhythmic events at follow-up.<\/jats:p>","DOI":"10.3390\/jcm13247659","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T03:46:02Z","timestamp":1734407162000},"page":"7659","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sacubitril\/Valsartan and Dapagliflozin in Patients with a Failing Systemic Right Ventricle: Effects on the Arrhythmic Burden"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6115-9435","authenticated-orcid":false,"given":"Giovanni Domenico","family":"Ciriello","sequence":"first","affiliation":[{"name":"Adult Congenital Heart Disease and Congenital and Familial Arrhythmias Unit, Monaldi Hospital, Leonardo Bianchi Street, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ippolita","family":"Altobelli","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Disease and Congenital and Familial Arrhythmias Unit, Monaldi Hospital, Leonardo Bianchi Street, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Fusco","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Disease and Congenital and Familial Arrhythmias Unit, Monaldi Hospital, Leonardo Bianchi Street, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6717-1953","authenticated-orcid":false,"given":"Diego","family":"Colonna","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Disease and Congenital and Familial Arrhythmias Unit, Monaldi Hospital, Leonardo Bianchi Street, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Correra","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Disease and Congenital and Familial Arrhythmias Unit, Monaldi Hospital, Leonardo Bianchi Street, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7416-9728","authenticated-orcid":false,"given":"Giovanni","family":"Papaccioli","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Disease and Congenital and Familial Arrhythmias Unit, Monaldi Hospital, Leonardo Bianchi Street, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Romeo","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Disease and Congenital and Familial Arrhythmias Unit, Monaldi Hospital, Leonardo Bianchi Street, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Scognamiglio","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Disease and Congenital and Familial Arrhythmias Unit, Monaldi Hospital, Leonardo Bianchi Street, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berardo","family":"Sarubbi","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Disease and Congenital and Familial Arrhythmias Unit, Monaldi Hospital, Leonardo Bianchi Street, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jacc.2022.06.020","article-title":"Long-Term Outcomes After Atrial Switch Operation for Transposition of the Great Arteries","volume":"80","author":"Broberg","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1093\/eurheartj\/ehad511","article-title":"End-stage heart failure in congenitally corrected transposition of the great arteries: A multicentre study","volume":"44","author":"Opotowsky","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1093\/eurheartj\/ehac288","article-title":"A new score for life-threatening ventricular arrhythmias and sudden cardiac death in adults with transposition of the great arteries and a systemic right ventricle","volume":"43","author":"Ladouceur","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e009848","DOI":"10.1161\/CIRCHEARTFAILURE.122.009848","article-title":"Safety and Efficacy of Sacubitril\/Valsartan in Patients with a Failing Systemic Right Ventricle: A Prospective Single-Center Study","volume":"16","author":"Fusco","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jchf.2024.01.006","article-title":"Dapagliflozin in Patients with a Failing Systemic Right Ventricle: Results From the DAPA-SERVE Trial","volume":"12","author":"Fusco","year":"2024","journal-title":"JACC Heart Fail."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1007\/s00392-019-01440-y","article-title":"Sacubitril\/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction","volume":"108","author":"Martens","year":"2019","journal-title":"Clin. Res. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"EVIDoa2400147","DOI":"10.1056\/EVIDoa2400147","article-title":"Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs\/CRT-Ds","volume":"3","author":"Benedikt","year":"2024","journal-title":"NEJM Evid."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/jce.15670","article-title":"Sacubitril\/valsartan: An antiarrhythmic drug?","volume":"33","author":"Huang","year":"2022","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_9","first-page":"e012517","article-title":"Antiarrhythmic and Anti-Inflammatory Effects of Sacubitril\/Valsartan on Post-Myocardial Infarction Scar","volume":"17","author":"Teis","year":"2024","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ejhf.2419","article-title":"Effect of sacubitril\/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF","volume":"24","author":"Curtain","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Liu, X., Liu, H., Wang, L., Zhang, L., and Xu, Q. (2022). Role of sacubitril-valsartan in the prevention of atrial fibrillation occurrence in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0263131"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"ehac544.505","DOI":"10.1093\/eurheartj\/ehac544.505","article-title":"Dapagliflozin but not empagliflozin prevents atrial fibrillation in an experimental whole-heart model","volume":"43","author":"Frommeyer","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00395-023-01022-0","article-title":"Acute antiarrhythmic effects of SGLT2 inhibitors-dapagliflozin lowers the excitability of atrial cardiomyocytes","volume":"119","author":"Paasche","year":"2024","journal-title":"Basic Res. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12933-024-02312-0","article-title":"The potential anti-arrhythmic effect of SGLT2 inhibitors","volume":"23","author":"Duan","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kolesnik, E., Scherr, D., Rohrer, U., Benedikt, M., Manninger, M., Sourij, H., and von Lewinski, D. (2022). SGLT2 Inhibitors and Their Antiarrhythmic Properties. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031678"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","article-title":"Effect of Dapagliflozin on Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial","volume":"141","author":"Zelniker","year":"2020","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Noh, H.J., Cha, S.J., Kim, C.H., Choi, S.W., Lee, C.H., and Hwang, J.K. (Clin. Res. Cardiol., 2024). Efficacy of dapagliflozin in improving arrhythmia-related outcomes after ablation for atrial fibrillation: A retrospective single-center study, Clin. Res. Cardiol., epub ahead of print.","DOI":"10.1007\/s00392-024-02389-3"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1111\/jce.16344","article-title":"SGLT2i effect on atrial fibrillation: A network meta-analysis of randomized controlled trials","volume":"35","author":"Mariani","year":"2024","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/14656566.2021.2003329","article-title":"The effect of dapagliflozin on ventricular arrhythmias, cardiac arrest, or sudden death in people with heart failure: A tick in another box for sodium-glucose cotransporter 2 inhibitors","volume":"23","author":"Koufakis","year":"2022","journal-title":"Expert. OpinPharmacother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1093\/eurheartj\/ehab560","article-title":"Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF","volume":"42","author":"Curtain","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12933-024-02309-9","article-title":"Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: The EMPA-ICD trial","volume":"23","author":"Fujiki","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/europace\/eux380","article-title":"Arrhythmias in congenital heart disease: A position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE","volume":"20","author":"Paul","year":"2018","journal-title":"Europace"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","article-title":"2020 ESC Guidelines for the management of adult congenital heart disease","volume":"42","author":"Baumgartner","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/CIRCULATIONAHA.117.031544","article-title":"Systemic Right Ventricle in Adults with Congenital Heart Disease: Anatomic and Phenotypic Spectrum and Current Approach to Management","volume":"137","author":"Brida","year":"2018","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jacc.2018.08.1028","article-title":"2018 AHA\/ACC Guideline for the Management of Adults with Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Stout","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/heartjnl-2020-318787","article-title":"Effect of medical treatment on heart failure incidence in patients with a systemic right ventricle","volume":"107","author":"Ladouceur","year":"2021","journal-title":"Heart"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"101443","DOI":"10.1016\/j.jacadv.2024.101443","article-title":"Propensity Score Analysis of Possible Medication Effects on Outcomes in Patients with Systemic Right Ventricles","volume":"4","author":"Misra","year":"2025","journal-title":"JACC Adv."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e025121","DOI":"10.1161\/JAHA.121.025121","article-title":"Cardiac Resynchronization Therapy for Adult Patients with a Failing Systemic Right Ventricle: A Multicenter Study","volume":"11","author":"Kharbanda","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/pace.14721","article-title":"Cardiac resynchronization therapy in adults with structural congenital heart disease and chronic heart failure","volume":"46","author":"Thompson","year":"2023","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/heartjnl-2019-316202","article-title":"Implantable cardiac electronic device therapy for patients with a systemic right ventricle","volume":"106","author":"Barracano","year":"2020","journal-title":"Heart"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/heartjnl-2022-322332","article-title":"Tolerability and beneficial effects of sacubitril\/valsartan on systemic right ventricular failure","volume":"109","author":"Nederend","year":"2023","journal-title":"Heart"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Neijenhuis, R.M.L., Nederend, M., Jongbloed, M.R.M., Ki\u00e8s, P., Rotmans, J.I., Vliegen, H.W., Jukema, J.W., and Egorova, A.D. (2023). The potential of sodium-glucose cotransporter 2 inhibitors for the treatment of systemic right ventricular failure in adults with congenital heart disease. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1093201"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7659\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:53:06Z","timestamp":1760115186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":32,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jcm13247659"],"URL":"https:\/\/doi.org\/10.3390\/jcm13247659","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,16]]}}}